OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Yumeko Kawano, Naomi J. Patel, Xiaosong Wang, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1742-1749
Open Access | Times Cited: 35
Yumeko Kawano, Naomi J. Patel, Xiaosong Wang, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1742-1749
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
Grace Qian, Xiaosong Wang, Naomi J. Patel, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 3, pp. e139-e150
Open Access | Times Cited: 42
Grace Qian, Xiaosong Wang, Naomi J. Patel, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 3, pp. e139-e150
Open Access | Times Cited: 42
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study
Md Yuzaiful Md Yusof, Jack Arnold, Benazir Saleem, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 2, pp. e88-e98
Open Access | Times Cited: 41
Md Yuzaiful Md Yusof, Jack Arnold, Benazir Saleem, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 2, pp. e88-e98
Open Access | Times Cited: 41
Impacto da infecção por COVID-19 em pacientes com doenças reumáticas autoimunes
Santiago Martín Sánchez Peralta, Karina Fernanda Pucha Aguinsaca, Homero Abel Chacho Aucay, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 1, pp. 2103-2118
Open Access | Times Cited: 23
Santiago Martín Sánchez Peralta, Karina Fernanda Pucha Aguinsaca, Homero Abel Chacho Aucay, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 1, pp. 2103-2118
Open Access | Times Cited: 23
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
Thomas Starkey, Maria C. Ionescu, Michaël Tilby, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Thomas Starkey, Maria C. Ionescu, Michaël Tilby, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Opportunities and limitations of B cell depletion approaches in SLE
Marit Stockfelt, Y.K. Onno Teng, Edward M Vital
Nature Reviews Rheumatology (2025)
Closed Access
Marit Stockfelt, Y.K. Onno Teng, Edward M Vital
Nature Reviews Rheumatology (2025)
Closed Access
Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study
Ying Li, Xiaolan Tian, Chao Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317319-e0317319
Open Access
Ying Li, Xiaolan Tian, Chao Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317319-e0317319
Open Access
Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study
Naomi J. Patel, Shruthi Srivatsan, Emily Kowalski, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005114-e005114
Open Access
Naomi J. Patel, Shruthi Srivatsan, Emily Kowalski, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005114-e005114
Open Access
Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
Alessandra Zaccardelli, Zachary S. Wallace, Jeffrey A. Sparks
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 3, pp. 175-184
Open Access | Times Cited: 11
Alessandra Zaccardelli, Zachary S. Wallace, Jeffrey A. Sparks
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 3, pp. 175-184
Open Access | Times Cited: 11
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies
Emily G. Oakes, Eilish Dillon, Katherine Buhler, et al.
Journal of Autoimmunity (2024) Vol. 148, pp. 103299-103299
Closed Access | Times Cited: 3
Emily G. Oakes, Eilish Dillon, Katherine Buhler, et al.
Journal of Autoimmunity (2024) Vol. 148, pp. 103299-103299
Closed Access | Times Cited: 3
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
Charalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 12, pp. 3375-3385
Open Access | Times Cited: 8
Charalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 12, pp. 3375-3385
Open Access | Times Cited: 8
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study
Emily Kowalski, Xiaosong Wang, Naomi J. Patel, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152286-152286
Closed Access | Times Cited: 7
Emily Kowalski, Xiaosong Wang, Naomi J. Patel, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152286-152286
Closed Access | Times Cited: 7
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study
Rathnam Venkat, Xiaosong Wang, Naomi J. Patel, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 10, pp. 2828-2837
Closed Access | Times Cited: 7
Rathnam Venkat, Xiaosong Wang, Naomi J. Patel, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 10, pp. 2828-2837
Closed Access | Times Cited: 7
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
Anne-Marie Svensson, Hanne‐Dorthe Emborg, Lars Erik Bartels, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 10, pp. 1359-1367
Closed Access | Times Cited: 6
Anne-Marie Svensson, Hanne‐Dorthe Emborg, Lars Erik Bartels, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 10, pp. 1359-1367
Closed Access | Times Cited: 6
Greetings from the editor 2023
Josef S Smolen
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 1, pp. 1-2
Open Access | Times Cited: 5
Josef S Smolen
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 1, pp. 1-2
Open Access | Times Cited: 5
Omicron variant infection in inflammatory rheumatological conditions – outcomes from a COVID-19 naive population in Aotearoa New Zealand
Jonathon Brooks, Anna Montgomery, Nicola Dalbeth, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 38, pp. 100843-100843
Open Access | Times Cited: 5
Jonathon Brooks, Anna Montgomery, Nicola Dalbeth, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 38, pp. 100843-100843
Open Access | Times Cited: 5
Impact of Risk Factors on COVID ‐19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID ‐19 Global Rheumatology Alliance Registry
Jinoos Yazdany, Anna Ware, Zachary S. Wallace, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 2, pp. 274-287
Open Access | Times Cited: 5
Jinoos Yazdany, Anna Ware, Zachary S. Wallace, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 2, pp. 274-287
Open Access | Times Cited: 5
Navigating use of rituximab during the COVID-19 pandemic
Mehreen Elahee, Sebastian E. Sattui
The Lancet Rheumatology (2023) Vol. 5, Iss. 2, pp. e63-e64
Open Access | Times Cited: 4
Mehreen Elahee, Sebastian E. Sattui
The Lancet Rheumatology (2023) Vol. 5, Iss. 2, pp. e63-e64
Open Access | Times Cited: 4
Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases
Libin Benny, Pankti Mehta, Sakir Ahmed, et al.
Rheumatology International (2023) Vol. 43, Iss. 6, pp. 1033-1039
Open Access | Times Cited: 4
Libin Benny, Pankti Mehta, Sakir Ahmed, et al.
Rheumatology International (2023) Vol. 43, Iss. 6, pp. 1033-1039
Open Access | Times Cited: 4
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
Andrea Picchianti Diamanti, Assunta Navarra, Alessandra Aiello, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1684-1684
Open Access | Times Cited: 4
Andrea Picchianti Diamanti, Assunta Navarra, Alessandra Aiello, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1684-1684
Open Access | Times Cited: 4
Greetings from the editor 2024/2
Josef S Smolen
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 685-686
Open Access | Times Cited: 1
Josef S Smolen
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 685-686
Open Access | Times Cited: 1
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan
Yuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
The Lancet Regional Health - Western Pacific (2022) Vol. 32, pp. 100661-100661
Open Access | Times Cited: 7
Yuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
The Lancet Regional Health - Western Pacific (2022) Vol. 32, pp. 100661-100661
Open Access | Times Cited: 7
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
Giuseppe A. Ramirez, Maria Gerosa, Chiara Bellocchi, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1273-1273
Open Access | Times Cited: 3
Giuseppe A. Ramirez, Maria Gerosa, Chiara Bellocchi, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1273-1273
Open Access | Times Cited: 3
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases
Yumeko Kawano, Xiaosong Wang, Naomi J. Patel, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 3, pp. 305-312
Open Access | Times Cited: 3
Yumeko Kawano, Xiaosong Wang, Naomi J. Patel, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 3, pp. 305-312
Open Access | Times Cited: 3
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
Grace Qian, Xiaosong Wang, Naomi J. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Grace Qian, Xiaosong Wang, Naomi J. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
